News Archive

FDA/ICH - E8(R1) General Considerations for Clinical Studies

19th April 2022

FDA/ICH - E8(R1) General Considerations for Clinical Studies.

Read More+

EMA - Public Consultation on the Approach of Protection of Personal data

13th April 2022

The European Medicines Agency has published for public consultation a draft guidance document on how to approach the protection of personal data and commercially confidential information in documents uploaded and published in the Clinical Trial Information System (CTIS).

Read More+

ICH - Analytical Procedure Development Q14

7th April 2022

ICH ANALYTICAL PROCEDURE DEVELOPMENT Q14 - Draft version

Read More+

EC - Pharmaceutical Committee 98th Meeting Minutes

6th April 2022

Summary record - 98th meeting of the Pharmaceutical Committee (20 January 2022)

Read More+

EMA - Advice to sponsors on managing the impact of the war in Ukraine on clinical trials

6th April 2022

Advice to sponsors on managing the impact of the war in Ukraine on clinical trials

Read More+

EMA - EMA establishes Cancer Medicines Forum with academia to optimise cancer treatments in clinical practice

6th April 2022

EMA establishes Cancer Medicines Forum with academia to optimise cancer treatments in clinical practice

Read More+

EMA - Public Consultation ICH guideline Q14 on analytical procedure development

6th April 2022

Public Consultation open on: ICH guideline Q14 on analytical procedure development

Read More+

EMA - Publication Consultation ICH guideline Q2(R2) on validation of analytical procedures for public consultation

6th April 2022

The European Medicines Agency has published ICH guideline Q2(R2) on validation of analytical procedures for public consultation.

Read More+

FDA - An Acceptable Circular of Information for the Use of Human Blood and Blood Components

6th April 2022

In March FDA published 'An Acceptable Circular of Information for the Use of Human Blood and Blood Components' - Guidance for Industry

Read More+

MHRA - Updated email address for Scientific Advice

6th April 2022

Medicines: get scientific advice from MHRA - New Email Address

Read More+